ATE206067T1 - Verfahren zur lieferung von zusammensetzungen aus dichten teilchen zur anwendung in transdermale teilchen abgabe - Google Patents

Verfahren zur lieferung von zusammensetzungen aus dichten teilchen zur anwendung in transdermale teilchen abgabe

Info

Publication number
ATE206067T1
ATE206067T1 AT97926146T AT97926146T ATE206067T1 AT E206067 T1 ATE206067 T1 AT E206067T1 AT 97926146 T AT97926146 T AT 97926146T AT 97926146 T AT97926146 T AT 97926146T AT E206067 T1 ATE206067 T1 AT E206067T1
Authority
AT
Austria
Prior art keywords
delivering
application
dense
particle
transdermal
Prior art date
Application number
AT97926146T
Other languages
English (en)
Inventor
David Francis Sarphie
Terry Lee Burkoth
Original Assignee
Powderject Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Powderject Res Ltd filed Critical Powderject Res Ltd
Application granted granted Critical
Publication of ATE206067T1 publication Critical patent/ATE206067T1/de

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/22—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by pressing in moulds or between rollers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/89—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
AT97926146T 1996-06-17 1997-06-17 Verfahren zur lieferung von zusammensetzungen aus dichten teilchen zur anwendung in transdermale teilchen abgabe ATE206067T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9612629.7A GB9612629D0 (en) 1996-06-17 1996-06-17 Method for providing dense particle compositions for use in transdermal particle delivery
PCT/GB1997/001636 WO1997048485A1 (en) 1996-06-17 1997-06-17 Method for providing dense particle compositions for use in transdermal particle delivery

Publications (1)

Publication Number Publication Date
ATE206067T1 true ATE206067T1 (de) 2001-10-15

Family

ID=10795416

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97926146T ATE206067T1 (de) 1996-06-17 1997-06-17 Verfahren zur lieferung von zusammensetzungen aus dichten teilchen zur anwendung in transdermale teilchen abgabe

Country Status (11)

Country Link
EP (1) EP0912239B1 (de)
JP (1) JP2000513338A (de)
AT (1) ATE206067T1 (de)
AU (1) AU3102597A (de)
CA (1) CA2258554C (de)
DE (1) DE69706988T2 (de)
DK (1) DK0912239T3 (de)
ES (1) ES2164348T3 (de)
GB (1) GB9612629D0 (de)
PT (1) PT912239E (de)
WO (1) WO1997048485A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7223739B1 (en) 1995-06-07 2007-05-29 Powderject Vaccines, Inc. Adjuvanted genetic vaccines
GB9619002D0 (en) * 1996-09-11 1996-10-23 Oxford Biosciences Ltd Particle delivery
GB9819272D0 (en) * 1998-09-03 1998-10-28 Andaris Ltd Microparticles
WO2000014547A1 (en) * 1998-09-04 2000-03-16 Powderject Research Limited Immunodiagnostics using particle delivery methods
EP1117382B1 (de) * 1998-10-01 2005-05-11 PowderJect Research Limited Sprühbeschichtete mikropartikel für nadellose spritzen
US6881723B1 (en) 1998-11-05 2005-04-19 Powderject Vaccines, Inc. Nucleic acid constructs
AU765429B2 (en) * 1999-01-22 2003-09-18 Powderject Research Limited Method of enhancing needleless transdermal powdered drug delivery
AU780397B2 (en) 1999-02-03 2005-03-17 Powderject Research Limited Hydrogel particle formulations
US7022320B1 (en) 1999-02-09 2006-04-04 Powderject Vaccines, Inc. Mycobacterium tuberculosis immunization
JP2002538195A (ja) * 1999-03-08 2002-11-12 パウダージェクト リサーチ リミテッド 生物活性化合物の持続放出用の無針注射器を使用する微粒子製剤の送達
US6190701B1 (en) 1999-03-17 2001-02-20 Peter M. Ronai Composition and method for stable injectable liquids
EP1220697B1 (de) 1999-10-11 2004-12-29 Felton International, Inc. Universelle antiinfektionsschutzvorrichtung für nadellose injektoren
US7196066B1 (en) 1999-11-03 2007-03-27 Powderject Vaccines, Inc. DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
US7887506B1 (en) 1999-11-23 2011-02-15 Pulse Needlefree Systems, Inc. Safety mechanism to prevent accidental patient injection and methods of same
ATE442858T1 (de) 2000-11-27 2009-10-15 Powderject Vaccines Inc Nukleinsäureadjuvantien
GB0103620D0 (en) * 2001-02-14 2001-03-28 Prometic Biosciences Ltd Sterile composition and its preparation
AU2002302814A1 (en) 2001-06-08 2002-12-23 Powderject Vaccines, Inc. Spray freeze-dried compositions
US7383084B2 (en) 2002-10-31 2008-06-03 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
US8133505B2 (en) 2002-10-31 2012-03-13 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
IL152574A (en) 2002-10-31 2009-09-22 Transpharma Medical Ltd A system for passing through the skin of dry items or dried medicines
US7662404B2 (en) 2002-10-31 2010-02-16 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized peptides and polypeptides
CA2702340C (en) 2006-10-12 2014-12-16 The University Of Queensland Compositions and methods for modulating immune responses
US8945565B2 (en) 2006-12-01 2015-02-03 Selexys Pharmaceuticals Corporation Methods of treating inflammatory or thrombotic conditions with anti-P-selectin antibodies
US20110212096A1 (en) 2006-12-01 2011-09-01 Scott Rollins Anti-p-selectin antibodies and methods of their use and identification
PL2662091T3 (pl) 2006-12-01 2019-05-31 Novartis Ag Przeciwciała skierowane przeciwko selektynie P i sposoby ich zastosowania do leczenia chorób zapalnych
NO3085381T3 (de) 2008-05-21 2018-09-15
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
DE102009002826A1 (de) * 2009-05-05 2010-11-11 Beiersdorf Ag Nadelfreies Injektionssystem zur kosmetischen Wirkstoffapplikation
ES2362525B8 (es) 2009-10-08 2013-01-03 Azurebio, S.L. Formulación de medicamentos en forma de agujas percutaneas penetrantes.
BR112013010926A2 (pt) 2010-11-01 2016-08-23 Univ Technology Sidney agentes imunomoduladores e seus usos
JP2015512371A (ja) 2012-03-23 2015-04-27 ザ・ユニバーシティ・オブ・クイーンズランド 免疫調節性作用物質およびその使用
EP3419606B1 (de) * 2016-02-23 2019-12-25 Merck Patent GmbH Glycin-partikel, sowie verfahren zur deren herstellung und deren verwendung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4018037A1 (de) * 1990-02-10 1991-08-14 Peroxid Chemie Gmbh Verfahren zur herstellung von peroxoborat-agglomeraten
US5147291A (en) * 1990-06-11 1992-09-15 Cukier A David Sound transmission apparatus for uniformly administering chemical composition through the skin

Also Published As

Publication number Publication date
ES2164348T3 (es) 2002-02-16
GB9612629D0 (en) 1996-08-21
EP0912239B1 (de) 2001-09-26
AU3102597A (en) 1998-01-07
PT912239E (pt) 2002-03-28
WO1997048485A1 (en) 1997-12-24
CA2258554A1 (en) 1997-12-24
DE69706988D1 (de) 2001-10-31
CA2258554C (en) 2006-08-15
DK0912239T3 (da) 2001-11-19
JP2000513338A (ja) 2000-10-10
EP0912239A1 (de) 1999-05-06
DE69706988T2 (de) 2002-04-04

Similar Documents

Publication Publication Date Title
DE69706988D1 (de) Verfahren zur lieferung von zusammensetzungen aus dichten teilchen zur anwendung in transdermale teilchen abgabe
EE9700176A (et) Kuivpulbriinhalaatorites kasutatav pulber, selle valmistamismeetod, selles kasutatavad osakesed ja meetod nende valmistamiseks ning pulbri lisandi kasutamine
ATE312600T1 (de) Verfahren und system zur behandlung dispergierbarer feiner pulver
DE60030721D1 (de) Pulverpartikel mit glatter oberfläche zur verwendung in der inhalationstherapie
ATE152573T1 (de) Protein mit zeitverabreichung
DE69840495D1 (de) Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben
DE59109215D1 (de) Werkstoff als ausgangsmaterial zur herstellung von knochenzement, verfahren zu seiner herstellung, und verfahren zur herstellung von knochenzement
DE69717997D1 (de) Verfahren zur herstellung von trockenen pulverteilchen, pulver hergestellt durch dieses verfahren und eine elektrode und eine vorrichtung zur anwendung in diesem verfahren
PL360254A1 (en) Pharmaceutical compositions
ATE241958T1 (de) Mahlverfahren zur herstellung feingemahlener medizinischer substanzen
DE69907717D1 (de) Pharmazeutische formulierung in form eines trockenen pulvers
IL142276A0 (en) Spray coated microparticles for use in needleless syringes
FR2587989B1 (fr) Compositions particulaires d'oxalates de metaux ferromagnetiques, sous forme de particules aciculaires submicroniques, leur preparation et leur application
HUP9802498A2 (hu) Eljárás és berendezés hatóanyagoknak valamely szűrőanyagra történő felhordására
GB2396627A (en) Composites comprising superabsorbent materials having a bimodal particle size distribution and methods of making the same
DE69408122D1 (de) Zusammensetzung aus mikropartikeln in verdichteter phase und verfahren
IL115869A0 (en) Implantable device for the administration of active substances to plants and a process for the production thereof
YU48978B (sh) Postupak za dobijanje preparata koji sadrži trandolapril i verapamil
FI954883A0 (fi) Matriisien valmistus
ATE498394T1 (de) Verfahren zur herstellung eines medikaments
Mobilization et al. Trends in Antibody Deal-Making & Financing

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee